11, 2024 — A drug approved to treat pulmonary arterial hypertension may be effective at managing hypertension and end-organ damage in patients with sickle cell disease, according to a new study.

The first evaluation for subclavian artery occlusive disease should always ... The main limitations of MRA and CTA are primarily related to the dye agents used and any artifact created by movement.

images, suggesting fresh ischemic changes. The bilateral VAs are not identified on MRA (right) with complete occlusion at the VA union (white arrow). The bilateral P-com arteries are of the fetal ...